3. On active immunosuppression for at least 3 months prior to scheduled surgery;
4. Scheduled for elective total shoulder arthroplasty;
5. Able and willing to provide written informed consent prior to any study specific procedures.
You may not be if
Patients with active infections or malignancies;
Patients undergoing shoulder arthroplasty for fracture or tumor;
Pregnancy or breastfeeding;
Unable to provide informed consent;
Patients with severe SLE with marked activity - as they should be offered enrollment in the observational arm. All such patients should remain on treatment to avoid worsening of disease activity;
Unable or without capacity to provide written informed consent prior to any study specific procedures.
Clareo Health | Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty